Vitiligo is caused by the destruction of melanocytes, the cells that produce pigment in your skin. The immune system mistakenly targets and kills these cells, leaving behind smooth white patches that can appear anywhere on the body. While the exact trigger varies from person to person, the process involves a combination of genetic susceptibility, immune system malfunction, oxidative stress inside the skin cells themselves, and sometimes environmental exposures that set everything in motion.
The Immune System Attacks Pigment Cells
Vitiligo is fundamentally an autoimmune condition. A specific type of immune cell, called a CD8+ T cell, identifies melanocytes as threats and destroys them. These killer T cells use two main methods: they release enzymes that punch holes in melanocyte membranes, and they activate a self-destruct signal on the melanocyte surface. Both routes lead to the same outcome: the pigment cell dies, and the skin in that area loses its color.
What makes vitiligo persist and spread is a feedback loop. The attacking T cells release a signaling molecule called interferon-gamma, which does two things simultaneously. It directly pushes more melanocytes toward death, and it sends out chemical signals that recruit additional T cells to the area. Those new T cells release more interferon-gamma, which recruits still more immune cells. This cycle explains why vitiligo patches can expand over time, sometimes rapidly. Some of these T cells become resident memory cells that stay in the skin long-term, which is why vitiligo often recurs in the same locations even after successful treatment.
Genetics Set the Stage
You don’t inherit vitiligo directly, but you can inherit a predisposition to it. Genome-wide studies have identified about 50 different genetic locations associated with vitiligo risk. Many of these genes are involved in immune regulation, meaning they influence how aggressively or precisely your immune system responds to perceived threats. Key susceptibility genes include ones that affect T cell activation and ones involved in the pigment-production pathway itself.
Family history matters, but less than you might expect. Roughly 9% to 36% of people with vitiligo have a relative with the condition, depending on the population studied. That means the majority of people who develop vitiligo have no family history at all. Having a genetic predisposition doesn’t guarantee you’ll develop it. Something else, whether stress, a chemical exposure, or a random immune event, typically has to flip the switch.
Oxidative Stress Weakens Melanocytes From Within
Before the immune system ever gets involved, melanocytes in vitiligo-prone skin may already be under strain. The process of making pigment is inherently stressful for these cells. Converting raw materials into melanin generates reactive oxygen species (a category of unstable molecules that damage cell structures), and the energy demands of pigment production require large amounts of cellular fuel. Generating that fuel in the mitochondria produces even more reactive oxygen species. Melanocytes essentially live in a harsh chemical environment of their own making.
In people with vitiligo, this internal stress gets out of control. Studies have found massive accumulations of hydrogen peroxide in vitiligo skin. Hydrogen peroxide is one of the most damaging reactive oxygen species, and at high levels it disrupts the enzymes melanocytes need to function and interferes with the pigment production pathway. Normally, cells have built-in systems to neutralize hydrogen peroxide, but in vitiligo these defenses appear to be overwhelmed.
There’s also a problem with the cellular cleanup process known as autophagy. Healthy cells routinely break down and recycle damaged proteins and structures. When this process fails in melanocytes, damaged material accumulates and triggers a protective stress response. Paradoxically, if that stress response stays activated too long, it stops being protective and starts causing harm. Research on melanocytes lacking key autophagy proteins shows they accumulate oxidative damage, age prematurely, and lose their ability to divide, a pattern that closely mirrors what happens in vitiligo skin. The weakened, stressed melanocyte becomes an easier target for the immune system.
Chemical Exposures and Skin Trauma
Certain chemicals can trigger vitiligo in people who are genetically susceptible. The main culprits are phenolic compounds, chemicals whose molecular structure resembles the building blocks of melanin. When melanocytes absorb these compounds, they process them as if they were pigment precursors, which generates toxic byproducts that damage or kill the cells. This damage then alerts the immune system.
Phenolic chemicals show up in surprising places. Hair dyes containing para-phenylenediamine have been linked to depigmentation. Lubricating oils, rubber products, adhesives, and even certain cosmetics contain compounds like 4-tert-butylphenol that have triggered vitiligo in documented cases. A skin-lightening ingredient called rhododendrol caused depigmentation in a large number of users in Japan, leading to its withdrawal from the market. In most of these cases, the white patches first appeared at the site of chemical contact before sometimes spreading to other areas.
Physical skin trauma can also trigger new patches through what’s called the Koebner phenomenon. Cuts, burns, friction, and even severe sunburn can provoke depigmentation in skin that was previously unaffected. The injury creates local inflammation that, in a person with the right genetic background, can activate the immune response against melanocytes. This is why some people notice new vitiligo patches appearing along a scratch line, at a surgical scar, or in areas where clothing repeatedly rubs.
The Autoimmune Connection
Vitiligo rarely travels alone. About 14% of adults with vitiligo also have thyroid disease, making it the most common accompanying condition. Psoriasis occurs in roughly 5%, rheumatoid arthritis in about 3%, and the hair-loss condition alopecia areata in nearly 3%. These overlapping conditions share many of the same immune-regulating genes, which is why they tend to cluster together. If you have vitiligo, your doctor will often check your thyroid function as a routine part of care.
The presence of other autoimmune conditions doesn’t cause vitiligo, but it does confirm that the underlying issue is a broadly overactive immune system rather than something specific to the skin. People with one autoimmune condition carry a higher baseline risk for developing others, and vitiligo is no exception.
How These Causes Work Together
No single factor causes vitiligo on its own. The current understanding is a three-hit model. First, genetic susceptibility creates melanocytes that are slightly less resilient and an immune system that’s slightly more aggressive. Second, internal oxidative stress or an external trigger (a chemical, an injury, emotional stress) damages enough melanocytes to release cellular debris that catches the immune system’s attention. Third, CD8+ T cells mount an attack against melanocytes, and the feedback loop of interferon-gamma signaling sustains and expands that attack over time.
This layered process explains why vitiligo is so unpredictable. Two people with the same genetic risk might have completely different outcomes depending on their chemical exposures, stress levels, or even how efficiently their melanocytes handle oxidative damage. It also explains why the condition can appear at any age, though it most commonly starts before 30, and why it can remain stable for years before suddenly progressing.